Cargando…
mRNA vaccines induce rapid antibody responses in mice
mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses compared...
Autores principales: | Gebre, Makda S., Rauch, Susanne, Roth, Nicole, Gergen, Janina, Yu, Jingyou, Liu, Xiaowen, Cole, Andrew C., Mueller, Stefan O., Petsch, Benjamin, Barouch, Dan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340693/ https://www.ncbi.nlm.nih.gov/pubmed/35915094 http://dx.doi.org/10.1038/s41541-022-00511-y |
Ejemplares similares
-
mRNA Vaccines Induce Rapid Antibody Responses in Mice
por: Gebre, Makda S., et al.
Publicado: (2021) -
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
por: Rauch, Susanne, et al.
Publicado: (2021) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
por: Roth, Nicole, et al.
Publicado: (2022) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
por: Roth, Nicole, et al.
Publicado: (2023) -
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
por: Gebre, Makda S., et al.
Publicado: (2021)